To assess whether breast cancer cells treated with varying concentrations of TPT-NCSe exhibited necrosis or apoptosis, the RealTime-Glo-Annexin V Apoptosis and Necrosis assay was utilised. This evidence concerns the gene ANXA5 and breast cancer.